Today on TAP: Injecting themselves into the military chain of command, they take judicial activism to a new depth.
coronavirus
Oil Company Profit-Gouging Began With the CARES Act
The benefits fossil fuel companies derived from COVID relief created the dynamic in the industry we see today.
Democracy Summer
The survival of Democrats in 2022 will depend heavily on turnout. Though Donald Trump will not be on the ballot, he will be our not-so-secret weapon.
Interest Rate Hikes Aren’t a Solution for Supply Shocks
Policymakers are employing the wrong tools for the current circumstances.
U.S., EU Back Pharma in Denying Access to Lifesaving COVID Products
A compromise effort to waive intellectual-property rights for vaccines, treatments, and tests will do little to expand supply, experts believe.
Time for Another Major Vaccine Push
Congressional Democrats are defunding vaccines long before the pandemic is over. Unacceptable.
COVID and the China Bottleneck
Today on TAP: Beijing’s extreme lockdowns are one more reason to unwind U.S. reliance on Chinese supplies.
Why Is Biden Pushing People Back to the Office?
How about converting our depopulated downtowns into affordable housing instead?
Why Giorgio Agamben Turned Antivax
In this episode of Left Anchor (#226), Prospect managing editor Ryan Cooper and Alexi the Greek discuss Giorgio Agamben’s paranoid turn during the pandemic.

